A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: Analysis of 865 consecutive liver transplant recipients

Journal of the American College of Surgeons

Volumn 220, Issue 4, 2015, Pages 416-427

  Agopian, Vatche G ^a   Harlander Locke, Michael ^a   Zarrinpar, Ali ^a   Kaldas, Fady M ^a   Farmer, Douglas G ^a   Yersiz, Hasan ^a   Finn, Richard S ^a   Tong, Myron ^a   Hiatt, Jonathan R ^a   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHOLESTEROL; TUMOR MARKER;

ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXPLANT; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL LYMPHOCYTE RATIO; NOMOGRAM; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TUMOR INVASION; ADVERSE EFFECTS; BLOOD; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; DISEASE FREE SURVIVAL; INCIDENCE; KAPLAN MEIER METHOD; LIVER NEOPLASMS; METABOLISM; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME; TRENDS; TUMOR VOLUME; UNITED STATES;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NOMOGRAMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SAN FRANCISCO; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TRANSPLANT RECIPIENTS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84925747839     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2014.12.025     Document Type: Conference Paper

References (57)

1. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. J.A. Davila, L. Henderson, and J.R. Kramer Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States Ann Intern Med 154 2011 85 93
3. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
4. H.B. El-Serag, and J.A. Davila Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol 4 2011 5 10
5. N.N. Rahbari, A. Mehrabi, and N.M. Mollberg Hepatocellular carcinoma: current management and perspectives for the future Ann Surg 253 2011 453 469
6. S. Iwatsuki, T.E. Starzl, and D.G. Sheahan Hepatic resection versus transplantation for hepatocellular carcinoma Ann Surg 214 1991 221 228 discussion 228-229
7. P. Moreno, E. Jaurrieta, and J. Figueras Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma? Transplant Proc 27 1995 2296 2298
8. B. Ringe, R. Pichlmayr, C. Wittekind, and G. Tusch Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients World J Surg 15 1991 270 285
9. D.H. Van Thiel, B. Carr, and S. Iwatsuki The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991 J Surg Oncol Suppl 3 1993 78 82
10. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
11. V. Mazzaferro, J.M. Llovet, and R. Miceli Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
12. F.Y. Yao, L. Ferrell, and N.M. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
13. S.S. Zheng, X. Xu, and J. Wu Liver transplantation for hepatocellular carcinoma: Hangzhou experiences Transplantation 85 2008 1726 1732
14. R. Wiesner, E. Edwards, and R. Freeman Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96
15. W.R. Kim, P.G. Stock, and J.M. Smith OPTN/SRTR 2011 Annual Data Report: liver Am J Transplant 13 Suppl 1 2013 73 102
16. J.P. Duffy, A. Vardanian, and E. Benjamin Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA Ann Surg 246 2007 502 509 discussion 509-511
17. G.C. Sotiropoulos, E.P. Molmenti, and C. Losch Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases Eur J Med Res 12 2007 527 534
18. H.A. Edmondson, and P.E. Steiner Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 1954 462 503
19. AJCC Cancer Staging Handbook 7th Edition 2010 American Joint Committee on Cancer Chicago
20. M. Wolbers, M.T. Koller, J.C. Witteman, and E.W. Steyerberg Prognostic models with competing risks: methods and application to coronary risk prediction Epidemiology 20 2009 555 561
21. T.E. Starzl The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967) J Am Coll Surg 195 2002 587 610
22. V.G. Agopian, H. Petrowsky, and F.M. Kaldas The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center Ann Surg 258 2013 409 421
23. S. Todo, and H. Furukawa Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan Ann Surg 240 2004 451 459 discussion 459-4661
24. E. Alba, C. Valls, and J. Dominguez Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation AJR Am J Roentgenol 190 2008 1341 1348
25. D.S. Lu, N.C. Yu, and S.S. Raman Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation Hepatology 41 2005 1130 1137
26. V. Mazzaferro, C. Battiston, and S. Perrone Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study Ann Surg 240 2004 900 909
27. G. Millonig, I.W. Graziadei, and M.C. Freund Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma Liver Transpl 13 2007 272 279
28. E. Tsochatzis, M. Garcovich, and L. Marelli Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma Liver Int 33 2013 944 949
29. P. Majno, E. Giostra, and G. Mentha Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials? Liver Transpl 13 11 Suppl 2 2007 S27 S35
30. A. Bharat, D.B. Brown, and J.S. Crippin Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival J Am Coll Surg 203 2006 411 420
31. T. Decaens, F. Roudot-Thoraval, and S. Bresson-Hadni Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 11 2005 767 775
32. D.A. DuBay, C. Sandroussi, and J.R. Kachura Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation HPB (Oxford) 13 2011 24 32
33. J.T. Heckman, M.B. Devera, and J.W. Marsh Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation Ann Surg Oncol 15 2008 3169 3177
34. A. Kornberg, U. Witt, and E. Matevossian Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC PLoS One 8 2013 e53960
35. O.B. Lao, J. Weissman, and J.D. Perkins Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation Clin Transplant 23 2009 874 881
36. P.M. Porrett, H. Peterman, and M. Rosen Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era Liver Transpl 12 2006 665 673
37. W.C. Chapman, M.B. Majella Doyle, and J.E. Stuart Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation Ann Surg 248 2008 617 625
38. U. Cillo, A. Vitale, and F. Grigoletto Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria Am J Transplant 7 2007 972 981
39. W. De Luna, D.Y. Sze, and A. Ahmed Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation Am J Transplant 9 2009 1158 1168
40. J. Lei, W. Wang, and L. Yan Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria J Gastrointest Surg 17 2013 1440 1446
41. G. Otto, S. Herber, and M. Heise Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transpl 12 2006 1260 1267
42. M. Ravaioli, G.L. Grazi, and F. Piscaglia Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria Am J Transplant 8 2008 2547 2557
43. F.Y. Yao, R. Hirose, and J.M. LaBerge A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation Liver Transpl 11 2005 1505 1514
44. F.Y. Yao, R.K. Kerlan Jr., and R. Hirose Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819 827
45. D. Gomez, S. Farid, and H.Z. Malik Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 2008 1757 1762
46. K.J. Halazun, A. Aldoori, and H.Z. Malik Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases Eur J Surg Oncol 34 2008 55 60
47. T. Motomura, K. Shirabe, and Y. Mano Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment J Hepatol 58 2013 58 64
48. S.R. Walsh, E.J. Cook, F. Goulder, T.A. Justin, and N.J. Keeling Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 2005 181 184
49. G.Y. Wang, Y. Yang, and H. Li A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation PLoS One 6 2011 e25295
50. K.J. Halazun, M.A. Hardy, and A.A. Rana Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma Ann Surg 250 2009 141 151
51. K. Berry, and G.N. Ioannou Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma Liver Transpl 19 2013 634 645
52. C. Duvoux, F. Roudot-Thoraval, and T. Decaens Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria Gastroenterology 143 2012 986 994 e3 quiz e14-15
53. S. Merani, P. Majno, and N.M. Kneteman The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma J Hepatol 55 2011 814 819
54. B. Hameed, N. Mehta, and G. Sapisochin Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria Liver Transpl 20 2014 945 951
55. T.M. Pawlik, A.L. Gleisner, and R.A. Anders Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility Ann Surg 245 2007 435 442
56. C.S. Cho, M. Gonen, and J. Shia A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma J Am Coll Surg 206 2008 281 291
57. J.H. Shim, M.J. Jun, and S. Han Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma Ann Surg 2014 Jun 19 [Epub ahead of print]